Where AI already picks you
This sample does not show a strong attribute lead yet.
AI Visibility Intelligence
Where BeatO Is Winning and Losing AI Buyer Visibility
Category: Digital Health Platform · Last analyzed: 2026-03-11
Live AI Knowledge Base
We've already fixed where BeatO is losing visibility.
Based on this analysis, we created pages that help BeatO show up when buyers search for these questions. These pages are already live at beatoapp-com.aikb.tryreadable.ai.
These pages directly address missing visibility
“app to connect with diabetes specialists in Mumbai”Not mentioned beforeNow covered“diabetes management platform that works offline in India”Not mentioned beforeNow covered“Sugar.fit vs Twin Health metabolic health platform”Not mentioned beforeNow covered“Twin Health vs Wellthy Therapeutics diabetes care”Not mentioned beforeNow covered
BeatO AI Influence Score
72
out of 100
Losing ~31% of buyers using AI search
Companies with higher scores are more likely to appear in AI-driven purchases.
Where AI already picks BeatO and where competitors win
Losing ~31% of buyers using AI search
BeatO is missing in 21% of tracked prompts right now. Every missed answer is a likely lost sale.
Where competitors beat you
No clear competitor-led attribute losses were found in this sample.
What to fix first
What to fix first
Create detailed comparison pages against Sugar.fit and Wellthy Therapeutics, highlighting BeatO's superior blood glucose tracking and integration capabilities
How AI tools evaluate BeatO across buyer and comparison queries
BeatO appears in 90% of sampled queries. Indian appears in 67%.
Confidence: HighSignal confidence is high for this sample.
| Brand | Buyer Mentions | Comparison Mentions | Total Mentions |
|---|---|---|---|
| BeatO Your brand | 83% | 100% | 90% |
| Indian | 83% | 44% | 67% |
| Sugar.fit | 67% | 44% | 57% |
| Wellthy Therapeutics | 8% | 56% | 29% |
Where competitors still intercept demand
Same underlying gaps, reframed around where competitors still capture buyer demand before BeatO gets recommended.
Buyer
diabetes management platform that works offline in India
Competitor leading: Indian
Create a buyer-intent page aligned to this query so BeatO appears in discovery results.
Where AI thinks you win vs lose
Directional view based on current AI response patterns, not a full product benchmark.
| Attribute | BeatO | Sugar.fit | Wellthy Therapeutics |
|---|---|---|---|
| Integrations | |||
| Customer support | |||
| Blood Glucose Tracking | |||
| Doctor Consultations | |||
| Medication Reminders | |||
| Diet Planning |
Where BeatO Is Losing AI Buyers to Competitors
Immediate risk
BeatO is absent in 17% of buyer-intent queries while Indian appears in 67% of tracked prompts.
Prompts you're missing
10%
Buyer query losses
17%
Comparison coverage
100%
Top competitor by mentions
Indian (67%)
What buyers hear first
BeatO is consistently positioned as an affordable, India-focused solution with basic glucose monitoring and regional language support, starting around ₹999/month
Sample-based
Who AI recommends instead
Sugar.fit is portrayed as a premium, comprehensive diabetes management platform with CGM integration and intensive coaching, priced higher at ₹2000-6000/month
Sample-based
What you lose if this continues
Wellthy Therapeutics is positioned as a clinically-validated digital therapeutic platform for multiple chronic conditions, with stronger healthcare provider integration
Sample-based
Act now
Create detailed comparison pages against Sugar.fit and Wellthy Therapeutics, highlighting BeatO's superior blood glucose tracking and integration capabilities
Every missed buyer-intent prompt is a competitor recommendation opportunity.
Detailed interpretation
- BeatO is consistently positioned as an affordable, India-focused solution with basic glucose monitoring and regional language support, starting around ₹999/month
- Sugar.fit is portrayed as a premium, comprehensive diabetes management platform with CGM integration and intensive coaching, priced higher at ₹2000-6000/month
- Wellthy Therapeutics is positioned as a clinically-validated digital therapeutic platform for multiple chronic conditions, with stronger healthcare provider integration
Where BeatO is missing in AI search results
- Offline functionality - BeatO is not mentioned in recommendations for offline diabetes management apps while competitors are
- Doctor consultation network - BeatO lacks visibility in queries about connecting with diabetes specialists in Mumbai
- Clinical validation studies - Competitors like Wellthy Therapeutics are noted for stronger clinical validation and healthcare provider partnerships
Where AI mentions BeatO in buyer and comparison queries
Recommended AI search optimizations for BeatO
- Create detailed comparison pages against Sugar.fit and Wellthy Therapeutics, highlighting BeatO's superior blood glucose tracking and integration capabilities
- Develop content positioning BeatO as category leader in 'Digital Diabetes Management' given the 79% visibility advantage over competitors
- Increase citations from medical journals and healthcare providers focusing on the 95% blood glucose tracking success rate to build authority
Everyday you may be losing hundreds of buyers using AI search. You should act now and stop losing customers to your competitors. Schedule a free call with us to learn how to win in AI search.